Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

MHRA extend swine flu adverse drug reaction portal

  • Comment

The MHRA have extended the swine flu adverse drug reaction (ADR) portal to include swine flu vaccines and seasonal vaccines.

In July 2009 the MHRA launched a special swine flu ADR portal for reporting suspected adverse drug reaction to oseltamivir (Tamiflu) and zanamivir (Relenza).

The MHRA now have extended use of this portal to include suspected ADRs to new swine flu vaccines and seasonal vaccines.

Reports should include;

  • the patient’s age;
  • a description of the suspected adverse reaction and outcome;
  • any underlying risk factors.

Click here for further information.

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.

Related Jobs